Randomized Phase II Trial of Carboplatin/Gemcitabine Followed by Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer

A Clinical Prognostic Model for Survival of Elderly Patients with Non-Small Cell Lung Cancer

AK Ganti;X Wang;TE Stinchcombe;YA Wang;K Kelly;R Paulus;JD Bradley;S Ramalingam;H Cohen;E Vokes;H Pang IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), accepted, oral

Chemotherapy outcomes by histological subtypes of non-small cell lung cancer: analysis of the SWOG database for antimicrotubule-platinum therapy

K Kelly;K Chansky;P Mack;P Lara;FR Hirsch;WA Franklin;A Wozniak;MJ Edelman;SK Williamson;DR Gandara Clinical Lung Cancer 14(6):627-635;

PMid: PMID23910067 | PMC number: PMC4122504

Chemotherapy outcomes by histologic subtype of non-small cell lung cancer (NSCLC): analysis of the SWOG database for antimicrotubule-platinum therapy

K Chansky;PC Mack;J Crowley;PN Lara;FR Hirsch;WA Franklin;DR Gandara Journal of Thoracic Oncology 4(9);suppl 1, abst. #B2.7, S326;

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials [PMID18202421]

PN Lara Jr;MW Redman;K Kelly;MJ Edelman;SK Williamson;JJ Crowley;DR Gandara Journal of Clinical Oncology 26(3):463-467

Alternative measures predicting clinical benefit in advanced non-small cell lung cancer (NSCLC) from Southwest Oncology Group (SWOG) randomized trials: implications for clincial trial design

PN Lara;MW Redman;K Kelly;MJ Edelman;SK Williamson;JJ Crowley;DR Gandara Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7006

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

MJ Edelman;JI Clark;K Chansky;K Albain;N Bhoopalam;GR Weiss;JK Giguere;K Kelly;J Crowley;DR Gandara Clinical Cancer Research 10:5022-5026

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine (CARB/G) followed by paclitaxel (P) or cisplatin/vinorelbine (C/V) followed by docetaxel (D).

MJ Edelman;JI Clark;K Chansky;J Crowley;K Albain;DR Gandara Proc of the American Society of Clinical Oncology 20:314a(#1254)